Work

[A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China].

Year: 2024

Type: other

Source: PubMed

DOI: 10.3760/cma.j.cn112152-20231223-00383

Authors: J Du, X Qiu, J Y Ni, Q L Wang, F Tong, H Z Sha, Y H Zhu, L Qi, W Cai, C Gao, X W Wei, M B Chen, Z Y Qian, M H Cai, M Tao, C L Wang, G C Zheng, H Jiang, A W Dai, J Wu, M H Zhao, X Q Li, B Lu, C B Wang, B R Liu

Institutions: Nanjing University of Chinese Medicine, Nanjing Drum Tower Hospital, Nanjing University, Wujiang District People's Hospital, Affiliated Hospital of Xuzhou Medical College, Nanjing First Hospital, First People's Hospital of Kunshan, Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, First Affiliated Hospital of Soochow University, Zhongda Hospital Southeast University, Changzhou No.2 People's Hospital, Traditional Chinese Medicine Hospital of Kunshan, The First People's Hospital of Changzhou, Affiliated Hospital of Jiangsu University, People's Hospital of Yangzhong, Yancheng Third People's Hospital

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405028884

Cites:

Cited by: 1

Related to: 10